Jazz Pharmaceuticals plc (JAZZ) Return on equity 2016–2025
Jazz Pharmaceuticals plc (JAZZ) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-8.2%FY2025 · since FY2016: 21.1% → -8.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -8.2% | -21.9 pp |
| FY2024 | 13.7% | +2.6 pp |
| FY2023 | 11.1% | +18.4 pp |
| FY2022 | -7.3% | +1.1 pp |
| FY2021 | -8.3% | -14.8 pp |
| FY2020 | 6.5% | -10.3 pp |
| FY2019 | 16.8% | +0.6 pp |
| FY2018 | 16.2% | -1.8 pp |
| FY2017 | 18.0% | -3.2 pp |
| FY2016 | 21.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice